Company Filing History:
2 out of 1,950 
1 out of 3,578 
1 out of 69 
Years Active: 2025
Title: Susan Moir: Innovator in HIV Research
Introduction
Susan Moir is a prominent inventor based in Washington, DC, known for her significant contributions to the field of HIV research. She has developed innovative solutions aimed at combating the HIV virus, showcasing her expertise and dedication to improving public health.
Latest Patents
Susan Moir holds a patent for her invention titled "Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope." This groundbreaking invention provides a multispecific anti-HIV antibody that binds to multiple epitopes on the HIV envelope protein. The antibody comprises an amino acid sequence that binds to a V1/V2 apex glycan epitope, a sequence that binds to a V3-base glycan region epitope, a sequence that binds to a CD4 binding site (CD4bs) epitope, a sequence that binds to a gp120/gp41 interface epitope, and a sequence that binds to a membrane proximal external region (MPER) epitope. This patent represents a significant advancement in the fight against HIV.
Career Highlights
Throughout her career, Susan has worked with esteemed organizations, including the University System of Maryland and the United States Department of Health and Human Services. Her work has been instrumental in advancing research and developing new therapeutic strategies for HIV.
Collaborations
Susan has collaborated with notable colleagues such as Yuxing Li and James Steinhardt, contributing to a collaborative environment that fosters innovation and scientific discovery.
Conclusion
Susan Moir's contributions to HIV research through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical science and public health.